The Immunobuddies Story
Our Mission
To translate complex immunotherapy science into real-world clinical practice through engaging, high-quality education that supports clinicians, empowers patients, and improves outcomes.
Our Vision
Our vision is to become a trusted platform for immunotherapy education and discussion, helping bridge the gap between advanced scientific knowledge and everyday clinical practice.
We strive to create a space where learning is continuous, collaborative, and accessible to all.
Listen to our podcast on
Partnership & Collaboration
We are medical oncologists and best buddies with a shared interest and passion for cancer immunotherapies, both the amazing outcomes achieved and the day to day challenges the pose. We love nothing more than a chat with friends and colleagues about all thing’s immunotherapy with Ricky despairing of Anna’s love for all things pharmacology and Anna marvelling at Ricky’s long held desire to give immunotherapy in the pub!
The Immunobuddies Story
A dedicated series created for patients and their loved ones, breaking down immunotherapy into simple, understandable conversations.
From how treatment works to managing side effects and what life looks like during and after therapy, these episodes are here to help you feel informed, reassured, and supported.
From the outset, the focus was deliberately different.
Learn More
Rather than purely discussing trial data, Immunobuddies focused on:
- how to recognise and manage toxicity
- how to make decisions in grey areas
- and how to deliver immunotherapy safely in the real world
The format was conversational, honest, and grounded in day-to-day clinical experience — designed to feel like the discussions clinicians have in corridors, MDTs, and on-call shifts.
What started as a small educational project quickly grew.
The podcast has now reached over 108,000 downloads across more than 120 countries, connecting a global community of clinicians navigating the same challenges. Episodes span tumour types, toxicity management, biomarkers, emerging therapies, and complex case discussions — creating a comprehensive, evolving library of immunotherapy education.
Alongside this growth, Immunobuddies has become closely aligned with the wider work of the Immuno-Oncology Clinical Network (IOCN), contributing to a broader ecosystem of education that includes national webinars, case-based discussions, and face-to-face learning events. Together, these initiatives aim to reduce variation in care, improve early recognition of toxicity, and ultimately enhance patient safety.
Importantly, the podcast has also expanded beyond clinicians.
A dedicated patient series was developed to provide clear, accessible information for patients and their families — recognising that understanding treatment is a key part of navigating the cancer journey.
At its heart, Immunobuddies remains grounded in its original purpose:
to make immunotherapy more understandable, more accessible, and safer for patients.
It reflects a belief that education doesn’t need to be complicated to be impactful — it needs to be relevant, practical, and shared. And perhaps most importantly, it reflects the idea that no one should be navigating immunotherapy alone.
Professor Anna Olsson-Brown
- MBChB (Hons) BSMBChB (Hons) BS c (Hons) PGCert (Dis) MRCP (Onc) FRCP (Ed) PhD
Anna Olsson-Brown is a Professor of Clinical Cancer Trials and a Consultant in Medical Oncology. She specialises in the systemic treatment of skin cancers; immunotherapeutic toxicities, early phase/translational clinical trials and NSS/CUP/acute oncology. She is an academic consultant at University College Cork/Cork University Hospital and works in the UK as an honorary academic at the University of Liverpool, an oncotoxicity consultant at University Hospitals Sussex, and within clinical leadership roles with both the Surrey and Sussex and West Midlands Cancer Alliances.
Professor Ricky Frazer
- Honorary Visiting Professor ; BSc, MSc (Med Educ), PgCert (Onc), PgCert (Clin Lead), PgCert (Acute Med), MAcadMEd, MRCP, AFFMLM
Ricky Frazer is an Honorary Visiting Professor in the Division of Infection and Immunity at Cardiff University and a Consultant Medical Oncologist at Velindre Cancer Services, specialising in immunotherapy, renal cancer, skin cancers and acute oncology. He is Clinical Director for Acute, Inpatient and Palliative Care and Clinical Lead for the multi award winning South East Wales Immunotherapy Toxicity Service and the Advanced Cellular Therapies and Complex Oncology team.